Uniphar (LON:UPR) Reaches New 12-Month High – What’s Next?

Uniphar plc (LON:UPR)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 240 ($3.18) and last traded at GBX 237 ($3.14), with a volume of 39509 shares. The stock had previously closed at GBX 235 ($3.11).

Analyst Upgrades and Downgrades

Separately, Shore Capital reissued a “buy” rating on shares of Uniphar in a research note on Tuesday, February 25th.

Uniphar Stock Up 0.9 %

The business has a 50 day simple moving average of GBX 221.78 and a 200-day simple moving average of GBX 197.96. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm has a market capitalization of £737.74 million, a price-to-earnings ratio of 16.48 and a beta of 0.75.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Shareholders of record on Thursday, April 24th will be issued a €0.01 ($0.01) dividend. This represents a yield of 0.47%. This is a positive change from Uniphar’s previous dividend of $0.01. The ex-dividend date is Thursday, April 24th. Uniphar’s payout ratio is presently 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.